title: First PI3k inhibitor launches into crowded hematology markets.
authors.forename: Chris
authors.initials: C
authors.lastname: Morrison
mesh_terms: D000970:Antineoplastic Agents; D004345:Drug Industry; D006801:Humans; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011687:Purines; D052999:Quinazolinones
chemical_list: D000970:Antineoplastic Agents; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011687:Purines; D052999:Quinazolinones; C552946:idelalisib